Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes

Endocrinology

Volumn 152, Issue 8, 2011, Pages 3155-3164

  Kanda, Naoko ^a   Hau, C S ^b   Tada, Y ^b   Tatsuta, A ^b   Sato, S ^b   Watanabe, S ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INSULIN RECEPTOR; INTERLEUKIN 8; JANUS KINASE 2 INHIBITOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOKINE CXCL10; FEMALE; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-8; JANUS KINASE 2; KERATINOCYTES; MICE; MICE, INBRED BALB C; NF-KAPPA B; NIACINAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PENTOSYLTRANSFERASES; PSORIASIS; RECEPTOR, INSULIN; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960710350     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2010-1481     Document Type: Article

References (39)

1. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ 2009 Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-691
2. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG 2008 Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-1211 (Pubitemid 351543220)
3. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Müller A, de Waal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A 2000 Upregulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-6632 (Pubitemid 30408849)
4. Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo Jr BF, Blauvelt A; National Psoriasis Foundation 2010 Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 63:1058-1069.
5. Setty AR, Curhan G, Choi HK 2007 Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 167:1670-1675 (Pubitemid 47280349)
6. Cerman AA, Bozkurt S, Sav A, Tulunay A, Elbaşi MO, Ergun T 2008 Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 159:820-826
7. Shibata S, Saeki H, Tada Y, Karakawa M, Komine M, Tamaki K 2009 Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci 55:62-63
8. Rho YH, Chung CP, Solus JF, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM 2010 Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 62:1259-1264
9. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H 2007 Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178:1748-1758 (Pubitemid 46154646)
10. Tanaka M, Nozaki M, Fukuhara A, Segawa K, Aoki N, Matsuda M, Komuro R, Shimomura I 2007 Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem Biophys Res Commun 359:194-201 (Pubitemid 46880493)
11. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I 1994 Cloning and characterization of the cDNA encoding a novel human pre-Bcell colony-enhancing factor. Mol Cell Biol 14:1431-1437
12. Revollo JR, Körner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, Milbrandt J, Kiess W, Imai S 2007 Nampt/PBEF/Visfatin regulates insulin secretion in β-cells as a systemic NAD biosynthetic enzyme. Cell Metab 6:363-375
13. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 V isfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
14. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2007 Retraction. Science 318:565
15. Kim JY, Bae YH, Bae MK, Kim SR, Park HJ, Wee HJ, Bae SK 2009 Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. Biochim Biophys Acta 1793:1759-1767
16. Bao JP, Chen WP, Wu LD 2009 Visfatin: a potential therapeutic target for rheumatoid arthritis. J Int Med Res 37:1655-1661
17. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D 2007 Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56:2829-2839 (Pubitemid 47502729)
18. Koczan D, Guthke R, Thiesen HJ, Ibrahim SM, Kundt G, Krentz H, Gross G, Kunz M 2005 Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 15:251-257 (Pubitemid 41020851)
19. Grange PA, Raingeaud J, Calvez V, Dupin N 2009 Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-κB and MAPK pathways. J Dermatol Sci 56:106-112
20. Sawa Y, Tsuruga E 2008 The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides. J Anat 212:654-663 (Pubitemid 351593971)
21. Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH 2008 Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48:1440-1450
22. Kanda N, Watanabe S 2007 Histamine enhances the production of human β-defensin-2 in human keratinocytes. Am J Physiol Cell Physiol 293:C1916-C1923
23. Romacho T, Azcutia V, Vázquez-Bella M, Matesanz N, Cercas E, Nevado J, Carraro R, Rodríguez-Mañas L, Sánchez-Ferrer CF, Peiró C 2009 Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia 52:2455-2463
24. Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, Galli M, Leo O, So A, De Smedt T 2008 Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 3:e2267
25. Kanda N, Watanabe S 2008 Leptin enhances human β-defensin-2 production in human keratinocytes. Endocrinology 149:5189-5198
26. Kanda N, Watanabe S 2007 Prolactin enhances interferon-γ-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148:2317-2325 (Pubitemid 46997044)
27. Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S 2009 Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39:996-1006
28. Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, Wei L, Pfeffer LM, Berliner JA 2007 Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem 282:31460-31468 (Pubitemid 350044874)
29. Roshak AK, Jackson JR, McGough K, Chabot-Fletcher M, Mochan E, Marshall LA 1996 Manipulation of distinct NFκB proteins alters interleukin-1β- induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J Biol Chem 271:31496-31501 (Pubitemid 26408607)
30. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B 2007 Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115:972-980 (Pubitemid 46328290)
31. Hu J, Nakano H, Sakurai H, Colburn NH 2004 Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis 25:1991-2003 (Pubitemid 39405920)
32. Wittwer T, Schmitz ML 2008 NIK and Cot cooperate to trigger NF-κB p65 phosphorylation. Biochem Biophys Res Commun 371:294-297
33. 2 through a histone deacetylase-independent mechanism. Arthritis Rheum 52:94-104
34. Wort SJ, Ito M, Chou PC, Mc Master SK, Badiger R, Jazrawi E, de Souza P, Evans TW, Mitchell JA, Pinhu L, Ito K, Adcock IM 2009 Synergistic induction of endothelin-1 by tumor necrosis factor α and interferon γ is due to enhanced NF-κB binding and histone acetylation at specific κB sites. J Biol Chem 284:24297-24305
35. Miyoshi K, Takaishi M, Nakajima K, Ikeda M, Kanda T, Tarutani M, Iiyama T, Asao N, DiGiovanni J, Sano S 2011 Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol 131:108-117
36. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J 2005 Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-49 (Pubitemid 40215836)
37. Wang H, Syrovets T, Kess D, Büchele B, Hainzl H, Lunov O, Weiss JM, Scharffetter-Kochanek K, Simmet T 2009 Targeting NF-κ B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol 183:4755-4763.
38. Tsai MC, Chen W, Cheng YW, Wang CY, Chen GY, Hsu TJ 2006 Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 16:251-253 (Pubitemid 43736143)
39. Abd El All HS, Shoukry NS, El Maged RA, Ayada MM 2007 Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris. Diagn Pathol 2:4